[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2021,71(3):209-249.
[2] RUMGAY H,ARNOLD M,FERLAY J,et al.Global burden of primary liver cancer in 2020 and predictions to 2040［J］.J Hepatol,2022,77(6):1598-1606.
[3] HEGDE PS,CHEN DS.Top 10 challenges in cancer immunotherapy［J］.Immunity,2020,52(1):17-35.
[4] ZENG L,SU J,QIU W,et al.Survival outcomes and safety of programmed cell death/programmed cell death ligand 1 inhibitors for unresectable hepatocellular carcinoma:result from phase III trials［J］.Cancer Control,2022,29:1389456324.
[5] ZHANG Q,HE Y,LUO N,et al.Landscape and dynamics of single immune cells in hepatocellular carcinoma［J］.Cell,2019,179(4):829-845.
[6] HUANG Y,GE W,ZHOU J,et al.The role of tumor associated macrophages in hepatocellular carcinoma［J］.J Cancer,2021,12(5):1284-1294.
[7] NETEA-MAIER RT,SMIT J,NETEA MG.Metabolic changes in tumor cells and tumor-associated macrophages:a mutual relationship［J］.Cancer Lett,2018,413:102-109.
[8] SHAPOURI-MOGHADDAM A,MOHAMMADIAN S,VAZINI H,et al.Macrophage plasticity,polarization,and function in health and disease［J］.J Cell Physiol,2018,233(9):6425-6440.
[9] MAZZONE M,MENGA A,CASTEGNA A.Metabolism and TAM functions-it takes two to tango［J］.Febs J,2018,285(4):700-716.
[10] PAJAK B,SIWIAK E,SOLTYKA M,et al.2-deoxy-d-glucose and its analogs:from diagnostic to therapeutic agents［J］.Int J Mol Sci,2019,21(1):234.
[11] SUN L,ZHOU F,SHAO Y,et al.Sedoheptulose kinase bridges the pentose phosphate pathway and immune responses in pathogen-challenged sea cucumber apostichopus japonicus［J］.Dev Comp Immunol,2020,109:103694.
[12] PAN L,HU L,ZHANG L,et al.Deoxyelephantopin decreases the release of inflammatory cytokines in macrophage associated with attenuation of aerobic glycolysis via modulation of PKM2［J］.Int Immunopharmacol,2020,79:106048.
[13] ZHANG T,ZHU X,WU H,et al.Targeting the ROS/PI3K/AKT/HIF-1alpha/HK2 axis of breast cancer cells:combined administration of polydatin and 2-deoxy-d-glucose［J］.J Cell Mol Med,2019,23(5):3711-3723.
[14] ZHANG Z,DENG X,LIU Y,et al.PKM2,function and expression and regulation［J］.Cell Biosci,2019,9:52.
[15] SHI Q,SHEN Q,LIU Y,et al.Increased glucose metabolism in TAMs fuels o-glcnacylation of lysosomal cathepsin B to promote cancer metastasis and chemoresistance［J］.Cancer Cell,2022,40(10):1207-1222.
[16] XU D,WANG Y,WU J,et al.ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway［J］.Cell Death Dis,2021,12(2):162.
[17] NING WR,JIANG D,LIU XC,et al.Carbonic anhydrase XII mediates the survival and prometastatic functions of macrophages in human hepatocellular carcinoma［J］.J Clin Invest,2022,132(7):e153110.
[18] WILLIAMS NC,O' NEILL L.A role for the krebs cycle intermediate citrate in metabolic reprogramming in innate immunity and inflammation［J］.Front Immunol,2018,9:141.
[19] ZHU X,GUO Y,LIU Z,et al.Itaconic acid exerts anti-inflammatory and antibacterial effects via promoting pentose phosphate pathway to produce ROS［J］.Sci Rep,2021,11(1):18173.
[20] XU J,ZHENG Y,ZHAO Y,et al.Succinate/IL-1beta signaling axis promotes the inflammatory progression of endothelial and exacerbates atherosclerosis［J］.Front Immunol,2022,13:817572.
[21] WU H,HAN Y,RODRIGUEZ SY,et al.Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages［J］.Embo Mol Med,2019,11(11):e10698.
[22] ZHANG Q,WANG H,MAO C,et al.Fatty acid oxidation contributes to IL-1beta secretion in M2 macrophages and promotes macrophage-mediated tumor cell migration［J］.Mol Immunol,2018,94:27-35.
[23] LI Q,WANG C,WANG Y,et al.HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways［J］.J Exp Clin Cancer Res,2018,37(1):231.
[24] ZAIDI NE,SHAZALI N,LEOW TC,et al.CD36-fatty acid-mediated metastasis via the bidirectional interactions of cancer cells and macrophages［J］.Cells,2022,11(22):3556.
[25] SOUKUPOVA J,MALFETTONE A,BERTRAN E,et al.Epithelial-mesenchymal transition (EMT) induced by TGF-beta in hepatocellular carcinoma cells reprograms lipid metabolism［J］.Int J Mol Sci,2021,22(11):5543.
[26] MORGAN MJ,KIM YS.Roles of RIPK3 in necroptosis,cell signaling,and disease［J］.Exp Mol Med,2022,54(10):1695-1704.
[27] WU L,ZHANG X,ZHENG L,et al.RIPK3 orchestrates fatty acid metabolism in tumor-associated macrophages and hepatocarcinogenesis［J］.Cancer Immunol Res,2020,8(5):710-721.
[28] BAI Y,YANG J,CUI Y,et al.Research progress of sirtuin4 in cancer［J］.Front Oncol,2020,10:562950.
[29] LI Z,LI H,ZHAO ZB,et al.SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARdelta signalling-mediated alternative activation of macrophages［J］.J Exp Clin Cancer Res,2019,38(1):469.
[30] KANG S,NAKANISHI Y,KIOI Y,et al.Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization［J］.Nat Immunol,2018,19(6):561-570.
[31] HASAN MN,CAPUK O,PATEL SM,et al.The role of metabolic plasticity of tumor-associated macrophages in shaping the tumor microenvironment immunity［J］.Cancers (Basel),2022,14(14):3331.
[32] OH MH,SUN IH,ZHAO L,et al.Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells［J］.J Clin Invest,2020,130(7):3865-3884.
[33] ZHANG B,TANG B,GAO J,et al.A hypoxia-related signature for clinically predicting diagnosis,prognosis and immune microenvironment of hepatocellular carcinoma patients［J］.J Transl Med,2020,18(1):342.
[34] BAILEY JD,DIOTALLEVI M,NICOL T,et al.Nitric oxide modulates metabolic remodeling in inflammatory macrophages through TCA cycle regulation and itaconate accumulation［J］.Cell Rep,2019,28(1):218-230.
[35] MATOS A,CARVALHO M,BICHO M,et al.Arginine and arginases modulate metabolism,tumor microenvironment and prostate cancer progression［J］.Nutrients,2021,13(12):4503.
[36] SHAN X,HU P,NI L,et al.Serine metabolism orchestrates macrophage polarization by regulating the IGF1-p38 axis［J］.Cell Mol Immunol,2022,19(11):1263-1278.
[37] DONNE R,LUJAMBIO A.The liver cancer immune microenvironment:therapeutic implications for hepatocellular carcinoma［J］.Hepatology,2023,77(5):1773-1796.
[38] MA Z,WANG LZ,CHENG JT,et al.Targeting hypoxia-inducible factor-1-mediated metastasis for cancer therapy［J］.Antioxid Redox Signal,2021,34(18):1484-1497.
[39] WANG D,ZHANG X,LU Y,et al.Hypoxia inducible factor 1alpha in hepatocellular carcinoma with cirrhosis: association with prognosis［J］.Pathol Res Pract,2018,214(12):1987-1992.
[40] ZHANG J,ZHANG Q,LOU Y,et al.Hypoxia-inducible factor-1alpha/interleukin-1beta signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment［J］.Hepatology,2018,67(5):1872-1889.
[41] FLORES A,SANDOVAL-GONZALEZ S,TAKAHASHI R,et al.Increased lactate dehydrogenase activity is dispensable in squamous carcinoma cells of origin［J］.Nat Commun,2019,10(1):91.
[42] BALTAZAR F,AFONSO J,COSTA M,et al.Lactate beyond a waste metabolite:metabolic affairs and signaling in malignancy［J］.Front Oncol,2020,10:231.
[43] CHEN P,ZUO H,XIONG H,et al.Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis［J］.Proc Natl Acad Sci USA,2017,114(3):580-585.
[44] BOHN T,RAPP S,LUTHER N,et al.Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages［J］.Nat Immunol,2018,19(12):1319-1329.
[45] BANTUG GR,GALLUZZI L,KROEMER G,et al.The spectrum of T cell metabolism in health and disease［J］.Nat Rev Immunol,2018,18(1):19-34.
[46] GOSWAMI KK,BANERJEE S,BOSE A,et al.Lactic acid in alternative polarization and function of macrophages in tumor microenvironment［J］.Hum Immunol,2022,83(5):409-417.
[47] WISSFELD J,WERNER A,YAN X,et al.Metabolic regulation of immune responses to cancer［J］.Cancer Biol Med,2022,19(11):1528-1542.
[48] O' NEILL LA,KISHTON RJ,RATHMELL J.A guide to immunometabolism for immunologists［J］.Nat Rev Immunol,2016,16(9):553-565.
[49] PACELLA I,PROCACCINI C,FOCACCETTI C,et al.Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth［J］.Proc Natl Acad Sci USA,2018,115(28):E6546-E6555.
[50] CHEN DP,NING WR,JIANG ZZ,et al.Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma［J］.J Hepatol,2019,71(2):333-343.
[51] HARMON C,ROBINSON MW,HAND F,et al.Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK cells in colorectal liver metastasis［J］.Cancer Immunol Res,2019,7(2):335-346.
[52] QUINN WR,JIAO J,TESLAA T,et al.Lactate limits T cell proliferation via the NAD(H) redox state［J］.Cell Rep,2020,33(11):108500.
[53] GU J,ZHOU J,CHEN Q,et al.Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-beta signaling in regulatory T cells［J］.Cell Rep,2022,39(12):110986.
[54] CHARBONNIER LM,CUI Y,STEPHEN-VICTOR E,et al.Functional reprogramming of regulatory T cells in the absence of Foxp3［J］.Nat Immunol,2019,20(9):1208-1219.
[55] VITALE I,MANIC G,COUSSENS LM,et al.Macrophages and metabolism in the tumor microenvironment［J］.Cell Metab,2019,30(1):36-50.
[56] LABADIE BW,BAO R,LUKE JJ.Reimagining IDO pathway inhibition in cancer immunotherapy via downstream focus on the tryptophan-kynurenine-aryl hydrocarbon axis［J］.Clin Cancer Res,2019,25(5):1462-1471.
[57] SISKA PJ,JIAO J,MATOS C,et al.Kynurenine induces T cell fat catabolism and has limited suppressive effects in vivo［J］.Ebiomedicine,2021,74:103734.
[58] CHEN CT,WU PH,HU CC,et al.Aberrant upregulation of indoleamine 2,3-dioxygenase 1 promotes proliferation and metastasis of hepatocellular carcinoma cells via coordinated activation of AhR and beta-catenin signaling［J］.Int J Mol Sci,2021,22(21):11661.
[59] EGUCHI A,IWASA M.The role of elevated liver-type fatty acid-binding proteins in liver diseases［J］.Pharm Res,2021,38(1):89-95.
[60] JIN R,HAO J,YI Y,et al.Regulation of macrophage functions by FABP-mediated inflammatory and metabolic pathways［J］.Biochim Biophys Acta Mol Cell Biol Lipids,2021,1866(8):158964.
[61] NEUSCHAFER-RUBE F,SCHON T,KAHNT I,et al.LDL-dependent regulation of TNFalpha/PGE(2) induced COX-2/mPGES-1 expression in human macrophage cell lines［J］.Inflammation,2023,46(3):893-911.
[62] LOFTUS RM,ASSMANN N,KEDIA-MEHTA N,et al.Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice［J］.Nat Commun,2018,9(1):2341.
[63] GLASNER A,LEVI A,ENK J,et al.NKp46 receptor-mediated interferon-gamma production by natural killer cells increases fibronectin 1 to alter tumor architecture and control metastasis［J］.Immunity,2018,48(1):107-119.
[64] KLAUSZ K,PEKAR L,BOJE AS,et al.Multifunctional NK cell-engaging antibodies targeting EGFR and NKp30 elicit efficient tumor cell killing and proinflammatory cytokine release［J］.J Immunol,2022,209(9):1724-1735.
[65] XU Y,HAO X,REN Y,et al.Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma［J］.Front Oncol,2022,12:1063423.
[66] FU C,JIANG A.Dendritic cells and CD8 T cell immunity in tumor microenvironment［J］.Front Immunol,2018,9:3059.
[67] PENG X,HE Y,HUANG J,et al.Metabolism of dendritic cells in tumor microenvironment:for immunotherapy［J］.Front Immunol,2021,12:613492.
[68] GROTH C,HU X,WEBER R,et al.Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression［J］.Br J Cancer,2019,120(1):16-25.
[69] CASSETTA L,POLLARD JW.Targeting macrophages:therapeutic approaches in cancer［J］.Nat Rev Drug Discov,2018,17(12):887-904.
[70] FAN N,ZHANG X,ZHAO W,et al.Covalent inhibition of pyruvate kinase M2 reprograms metabolic and inflammatory pathways in hepatic macrophages against non-alcoholic fatty liver disease［J］.Int J Biol Sci,2022,18(14):5260-5275.
[71] KUDO M.Combination cancer immunotherapy in hepatocellular carcinoma［J］.Liver Cancer,2018,7(1):20-27.
[72] TANG H,LIANG Y,ANDERS RA,et al.PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression［J］.J Clin Invest,2018,128(2):580-588.
[73] LU L G,ZHOU ZL,WANG XY,et al.PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma［J］.GUT,2022,71(12):2551-2560.
[74] SU P,WANG Q,BI E,et al.Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages［J］.Cancer Res,2020,80(7):1438-1450.